MedTrace Logo

Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study

NCT02937233 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-08-23

No results posted yet for this study

Summary

This is a phase 1 trial of one or more administrations of Zika Virus Purified Inactivated Vaccine (ZPIV). The trial will be conducted under a placebo controlled, double-blind, randomized allocation of study product. There are four groups in the study. Each group is testing a different vaccine schedule.

Conditions

  • Zika

Interventions

BIOLOGICAL

Zika Virus Purified Inactivated Vaccine

OTHER

Placebo

Sponsors & Collaborators

  • Walter Reed Army Institute of Research (WRAIR)

    collaborator FED

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Kathryn Stephenson

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-08
Primary Completion
2018-06-04
Completion
2018-06-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937233 on ClinicalTrials.gov